Li-Jun Sha

Title: The Innovative Contributions of Li-Jun Sha

Introduction

Li-Jun Sha is a prominent inventor based in Beijing, China. She has made significant strides in the field of analgesics, particularly focusing on the development of low- or non-addictive opioid medications. Her work aims to address the pressing issue of opioid addiction while providing effective pain relief.

Latest Patents

Li-Jun Sha holds a patent for a method that identifies low or non-addictive opioid analgesics. The patent describes a bioassay that utilizes an electrophysiological method and a cell culture system of dorsal-root ganglion (DRG) neurons. This innovative approach allows for the screening and identification of opioids that have a high potential for use as low- or non-addictive analgesics. The invention also highlights a specific group of opioid alkaloids and their analogues, which activate only inhibitory opioid receptor functions, thereby minimizing the risk of addiction. Notably, the patent emphasizes the use of etorphine or dihydroetorphine from the opioid alkaloid family as potential treatments for both pain and opioid addiction.

Career Highlights

Li-Jun Sha is associated with United Biomedical, Inc., where she continues to contribute to research and development in the field of pain management. Her innovative methods and dedication to finding safer alternatives to traditional opioids have positioned her as a key figure in the industry.

Collaborations

Li-Jun Sha has collaborated with notable colleagues, including Bo-yi Qin and Xiong-qi Gong. These partnerships have further enhanced her research efforts and expanded the impact of her work in the field of analgesics.

Conclusion

Li-Jun Sha's contributions to the development of low- or non-addictive opioid analgesics represent a significant advancement in pain management. Her innovative methods and dedication to addressing opioid addiction are commendable and highlight the importance of continued research in this critical area.